Disc Medicine, Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$236.0M | -$129.7M | -$91.1M | -$47.5M | -$30.9M |
| Operating expenses | $236.0M | $129.7M | $91.1M | $47.5M | $30.9M |
| Cash from operations | -$180.4M | -$93.9M | -$73.5M | -$42.3M | -$27.5M |
| Capital expenditure | $933,000 | $505,000 | $89,000 | $151,000 | $68,000 |
| Free cash flow | -$181.3M | -$94.4M | -$73.6M | -$42.4M | -$27.6M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $806.9M | $496.8M | $368.0M | $200.2M | $92.4M |
| Total liabilities | $67.1M | $53.2M | $22.9M | $23.6M | $14.8M |
Shares outstanding 38.2M · Free float 57.0%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.